A significant discovery in cancer study is occurring with the use of nanobodies to re-engage damaged p53. This essential tumor suppressor protein is frequently inactivated in many forms of malignancies, causing https://whitebookmarks.com/story22037020/mini-antibodies-reactivate-the-p53-protein-the-potential-approach-for-malignant-management